PMC:7402624 / 36240-36502 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T335","span":{"begin":43,"end":46},"obj":"Body_part"},{"id":"T336","span":{"begin":62,"end":67},"obj":"Body_part"}],"attributes":[{"id":"A335","pred":"fma_id","subj":"T335","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A336","pred":"fma_id","subj":"T336","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Longitudinal patterns (see Methods) of (E) HLA-DR+CD38+ CD4 T cells or (F) PBs in COVID-19 patients shown as frequency and representative flow cytometry plots. (G) Spearman correlations of clinical parameters with longitudinal fold changes in immune populations."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1297","span":{"begin":50,"end":54},"obj":"Gene"},{"id":"1298","span":{"begin":56,"end":59},"obj":"Gene"},{"id":"1301","span":{"begin":91,"end":99},"obj":"Species"},{"id":"1303","span":{"begin":75,"end":78},"obj":"Chemical"},{"id":"1307","span":{"begin":82,"end":90},"obj":"Disease"}],"attributes":[{"id":"A1297","pred":"tao:has_database_id","subj":"1297","obj":"Gene:952"},{"id":"A1298","pred":"tao:has_database_id","subj":"1298","obj":"Gene:920"},{"id":"A1301","pred":"tao:has_database_id","subj":"1301","obj":"Tax:9606"},{"id":"A1303","pred":"tao:has_database_id","subj":"1303","obj":"MESH:D007854"},{"id":"A1307","pred":"tao:has_database_id","subj":"1307","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Longitudinal patterns (see Methods) of (E) HLA-DR+CD38+ CD4 T cells or (F) PBs in COVID-19 patients shown as frequency and representative flow cytometry plots. (G) Spearman correlations of clinical parameters with longitudinal fold changes in immune populations."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T289","span":{"begin":82,"end":90},"obj":"Disease"}],"attributes":[{"id":"A289","pred":"mondo_id","subj":"T289","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Longitudinal patterns (see Methods) of (E) HLA-DR+CD38+ CD4 T cells or (F) PBs in COVID-19 patients shown as frequency and representative flow cytometry plots. (G) Spearman correlations of clinical parameters with longitudinal fold changes in immune populations."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T611","span":{"begin":50,"end":54},"obj":"http://purl.obolibrary.org/obo/PR_000001408"},{"id":"T612","span":{"begin":56,"end":59},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T613","span":{"begin":60,"end":67},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"Longitudinal patterns (see Methods) of (E) HLA-DR+CD38+ CD4 T cells or (F) PBs in COVID-19 patients shown as frequency and representative flow cytometry plots. (G) Spearman correlations of clinical parameters with longitudinal fold changes in immune populations."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T263","span":{"begin":47,"end":49},"obj":"Chemical"}],"attributes":[{"id":"A263","pred":"chebi_id","subj":"T263","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"}],"text":"Longitudinal patterns (see Methods) of (E) HLA-DR+CD38+ CD4 T cells or (F) PBs in COVID-19 patients shown as frequency and representative flow cytometry plots. (G) Spearman correlations of clinical parameters with longitudinal fold changes in immune populations."}

{"project":"LitCovid-sentences","denotations":[{"id":"T210","span":{"begin":0,"end":262},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Longitudinal patterns (see Methods) of (E) HLA-DR+CD38+ CD4 T cells or (F) PBs in COVID-19 patients shown as frequency and representative flow cytometry plots. (G) Spearman correlations of clinical parameters with longitudinal fold changes in immune populations."}